Skip to content

Author

M. Mikov

We have 2 of 359 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Ursodeoxycholic acid as a potential cardioprotective agent: molecular mechanisms, experimental evidence, and clinical perspectives

Cardiovascular diseases remain the leading cause of morbidity and mortality worldwide, despite significant advances in diagnostics and pharmacotherapy. This persistent burden has shifted attention toward adjunct therapeutic strategies targeting key mechanisms of myocardial and vascular injury, including oxidative stres...

T. Milivojac, Nataša Stojaković, M. Mikov et al. · 0 citations
Review Open access Aug 2026

Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome–drug–host triad

This narrative review synthesizes contemporary evidence on the contribution of the gut microbiota to the pathogenesis of metabolic syndrome and T2DM and critically examines bidirectional interactions between the microbiome and antidiabetic therapy within the framework of pharmacomicrobiomics.

David Strilić, Bojan Stanimirov, N. Pavlović et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.